The effect of N-terminal acetylation and the inhibition activity of acetylated enkephalins on the aminopeptidase M-catalyzed hydrolysis of enkephalins

Peptides

Volumn 20, Issue 8, 1999, Pages 963-970

  Jayawardene, Dhammika S ^a   Dass, Chhabil ^a  

^a University of Memphis   (United States)

Author keywords

Acetylated leucine enkephalin; Acetylated methionine enkephalin; Aminopeptidase M; Electrospray ionization mass spectrometry; Leucine enkephalin; Methionine enkephalin; Proteolytic stability

Indexed keywords

ENKEPHALIN DERIVATIVE; LEUCINE ENKEPHALIN; METENKEPHALIN; MICROSOMAL AMINOPEPTIDASE;

ACETYLATION; ARTICLE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IN VITRO STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ACETYLATION; AMINOPEPTIDASES; CATALYSIS; ENKEPHALINS; HYDROLYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032858184     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00089-3     Document Type: Article

References (28)

1. Almenoff J., Orlowski M. Membrane-bound kidney neutral mettalloendopeptidase interaction with synthetic substrates, natural substrates, natural peptides and inhibitors . Biochemistry. 22:1986;590-599.
2. Beamount A., Fournie-Zalaski M., Rocques B.P. Neutral endopeptidase-24.11 structure, and design and clinical use of inhibitors . Hooper N.M. Zinc metalloproteases in health and disease. 1996;105-129 Taylor & Francis, London.
3. Benter I.F., Hirsh E.M., Tuchman A.J., Ward P.E. N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid. Biochem Pharmacol. 40:1990;465-472.
4. Boarder M.R., McArdale W. Breakdown of small enkephalin derivatives and adrenal peptide E by human plasma. Biochem Pharmacol. 35:1986;1043-1047.
5. Cornish-Bowden A. Fundamentals of enzyme kinetics. 1995;Portland Press, London.
6. Dass C. The role of a liquid matrix in controlling FAB-induced fragmentation. J Mass Spectrom. 31:1996;77-82.
7. Dass C. HPLC-electrospray ionization mass spectrometry. Settle F. Handbook of instrumental techniques for analytical chemistry. 1997;647-664 Prentice Hall, Upper Saddle River, NJ.
8. Dass C. Recent development and applications of HPLC-electrospray ionization mass spectrometry. Curr Org Chem. 3:1999;193-209.
9. Dass C., Mahalakshmi P. Phosphorylation of enkephalins enhances their proteolytic stability. Life Sci. 58:1996;1039-1045.
10. Delange R.J., Smith E.L. Leucine aminopeptidas and other N-terminal exopeptidases. Boyer P.D. The enzymes, vol. 3. 1971;81-105 Academic Press, New York.
11. Delmas B., Gelfi J., L'Haridon R., Vogel L.K., Sjostrom H., Noren O., Laude H. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature (London). 357:1992;417-420.
12. 3H]-methionine-enkephalin by various rat tissues in vivo and in vitro. Life Sci. 21:1977;907-914.
13. Frederickson R.C.A. Progress in the use of enkephalin analogs. Rapaka R.S., Hawks R.L. Opioid peptides, molecular pharmacology, biosynthesis, and analysis NIDA Research Monograph 70. 1986;367-384 NIDA Research Monograph Series, Rockville, MD.
14. Hambrook J.M., Morgan B.A., Rance M.J., Smith C.F.C. Deactivation of enkephalins by rat and human plasma and rat-brain homogenates. Nature. 262:1976;782-783.
15. Hollt V. Multiple endogenous opioid peptides. Trends Neurosci. 6:1983;24-26.
16. Palmer T. Understanding enzymes. 1985;Ellis Limited, West Sussex.
17. Peterson S.J., Robson L.E., Wkosterlitz H. Opioid receptors. Udenfriend S., Meienhofer J. The peptides, vol. 6. 1984;147-189 Academic Press, New York.
18. Rapaka RS. Frontiers of research in the medicinal chemistry and molecular pharmacology of opoid peptides. In: Rapaka RS, Barnett G, Hawks RL, editors. Opioid peptides. Medicinal Chemistry NIDA Research Monograph 69. Rockville, MD: NIDA Research Monograph Series, 1986. pp. 3-20.
19. Schulteis G., Weinberger S.B., Martinez J.L. Jr. Plasma uptake and in vivo metabolism of [Leu]-Enkephalin following its intraperitoneal (i.p.) administration to rats. Peptides. 10:1989;913-919.
20. Segel I.H. Enzyme kinetics. 1975;John Wiley & Sons, New York.
21. Shibanoki S., Weinberger S.B., Beniston D., Nudelman K.A., Schulteis G., Bennett E.L., Rosenzweig M.R., Ishikawa K., Martinez J.L. Jr. Hydrolysis of [Leu]-enkephalin by chick plasma in vitro. J Pharmacol Exp Ther. 256:1991;650-655.
22. Shibanoki S., Weinberger S.B., Ishikawa K., Martinez J.L. Jr. Further characterization of the in vitro hydrolysis of [Leu]-enkephalin and [Met]-enkephalin in rat plasma-HPLC-ECD measurement of substrate and metabolite concentrations. Regul Pep. 32:1991;267-268.
23. Shimamura M., Hazato T., Hachisu M., Katayama T. Inhibition of a membrane bound enkephalins degrading aminopeptidase by bestatin analogs. J Neurochem. 43:1984;888-890.
24. Thorsett E.D., Wyvratt M.J. Inhibition of zinc peptidases that hydrolyze neuropeptides. Turner A.J. Nuropeptides and their peptidases. 1987;229-284 Ellis Horwood, Chichester.
25. Turck C.W. Identification of phosphotyrosine residues in peptides by HPLC on-line derivative spectroscopy. Peptide Res. 5:1992;155-160.
26. Wang J., Cooper M.D. Aminopeptidases structure and biological function. Hooper N.M. Zinc metalloproteases in health and disease. 1996;131-151 Taylor & Francis, London.
27. 2-[L-Leu]-enkephalin in rat plasma. J Pharmacol Exp Ther. 247:1988;129-135.
28. Zhu X., Dass C. Analysis of phosphoenkephalins by combined HPLC and electrospray ionization mass spectrometry. J Liq Chrom Rel Technol. 22:1999;1635-1647.